Celularity
CELU
38 hedge funds and large institutions have $232M invested in Celularity in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 4 closing their positions.
375% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 4
171% more capital invested
Capital invested by funds: $85.6M → $232M (+$146M)
148% more call options, than puts
Call options by funds: $12.7M | Put options by funds: $5.13M
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
58% more funds holding
Funds holding: 24 → 38 (+14)
0.59% more ownership
Funds ownership: 1.35% → 1.95% (+0.59%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIC
Starr International Company
Zug,
Switzerland
|
+$39.8M |
| 2 |
CVSC
C.V. Starr & Co
New York
|
+$19.9M |
| 3 |
Millennium Management
New York
|
+$2.49M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.48M |
| 5 |
HF
HRT Financial
New York
|
+$377K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.3M |
| 2 |
PT
Palantir Technologies
Aventura,
Florida
|
-$1.71M |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
-$173K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$64.9K |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$59.9K |
CELU Hedge Fund Activity: Q1 2022 in Review
38 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q1 2022, worth a combined $232M — up 171% from $85.6M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new CELU positions and 4 closed out — a net gain of 15 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was Starr International Company, adding an estimated $39.8M. The largest seller was Fidelity Investments, exiting entirely with an estimated $3.3M sold.
- 38 institutional investors held Celularity (CELU) as of Q1 2022, up from 24 in Q4 2021.
- Funds reported $232M of Celularity stock for Q1 2022, up 171% quarter-over-quarter.
- 19 funds opened new Celularity positions in Q1 2022 and 4 closed out, a net change of +15 holders.
- The largest Celularity buyer in Q1 2022 was Starr International Company, an estimated $39.8M added.
- The largest Celularity seller in Q1 2022 was Fidelity Investments, an estimated $3.3M sold.
Based on aggregated 13F filings for Q1 2022.